Skip to main content

Shopping Cart

You're getting the VIP treatment!

Item(s) unavailable for purchase
Please review your cart. You can remove the unavailable item(s) now or we'll automatically remove it at Checkout.
itemsitem
itemsitem

Recommended For You

Loading...
  • Innovation versus Financialization in the US Pharmaceutical Industry

    Series series Elements in Corporate Governance
    Mandated by the Inflation Reduction Act of 2022, the US government is negotiating with pharmaceutical companies over the 'maximum fair price' of ten drugs widely used by Medicare patients. The pharmaceutical companies contend that a 'fair' price is a 'value-based price' that enables their shareholders to capture the value the drug creates for society and warn that lowering drug prices will reduce ... Read more

    $23.99 CAD

  • From Financialisation to Innovation in UK Big Pharma

    AstraZeneca and GlaxoSmithKline

    Series series Elements in Reinventing Capitalism
    The tension between innovation and financialisation is central to the business corporation. Innovation entails a 'retain-and-reinvest' allocation regime that can form a foundation for stable and equitable economic growth. Driven by shareholder-value ideology, financialisation entails a shift to 'downsize-and-distribute'. This Element investigates this tension in global pharmaceuticals, focusing on ... Read more

    $23.99 CAD

People who read these also enjoyed

  • Healthcare Investing: Profiting from the New World of Pharma, Biotech, and Health Care Services

    Is your portfolio in peak health?Ranking among the world's largest markets, the $2.5 trillion health care industry is growing at an unprecedented rate. According to Miller Tabak + Co.'s health care strategist Les Funtleyder, major structural renovations to the system are imminent. “Health care is entering an era of reform,” Funtleyder writes, “and with reform comes change and the opportunity for ... Read more

    $76.99 CAD

  • From Breakthrough to Blockbuster

    The Business of Biotechnology

    Financial Times Business Top Title March 2022 How could a large collection of small companies, most with fewer than 50 employees, rise to compete with Big Pharma, one of the world's most breathtakingly expensive and highly regulated industries? Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these ... Read more

    $32.99 CAD

  • The Business of Healthcare Innovation

    Edited by Lawton Robert Burns ...
    The Business of Healthcare Innovation is a wide-ranging analysis of business trends in the manufacturing segment of the healthcare industry. It provides a thorough overview and introduction to the innovative sectors fueling improvements in healthcare: pharmaceuticals, biotechnology, platform technology, medical devices and information technology. For each sector, the book examines the basis and ... Read more

    $51.99 CAD

  • The Funding of Biopharmaceutical Research and Development

    Series series Woodhead Publishing Series in Biomedicine
    The funding of biopharmaceutical research and development provides a comprehensive critical review of the funding of research and development (R&D) in the human biopharmaceutical market sector. It addresses both private and public funding sources available in the US and internationally. The biopharmaceutical market is among the most research-intensive market sectors globally. Clinical researchers ... Read more

    $190.39 CAD

  • The Truth About the Drug Companies

    How They Deceive Us and What to Do About It

    by Marcia Angell ...
    During her two decades at The New England Journal of Medicine, Dr. Marcia Angell had a front-row seat on the appalling spectacle of the pharmaceutical industry. She watched drug companies stray from their original mission of discovering and manufacturing useful drugs and instead become vast marketing machines with unprecedented control over their own fortunes. She saw them gain nearly limitless ... Read more

    $12.99 CAD

  • NUMBERS FOR SUCCESSFUL BUSINESS

    “Numbers for successful business” writing was originated by Grabovoi Grigori Petrovich in the Russian language in 2004, was completed by Grabovoi G.P.The work includes number series presented that can be used in accordance with terms, definitions and notions in business for successful development of one’s own business on the basis of technologies of eternal development.Economy is considered as any ... Read more

    $40.14 CAD

  • Building Biotechnology

    Biotechnology Business, Regulations, Patents, Law, Policy and Science

    by Yali Friedman ...
    Building Biotechnology helps readers understand the business of biotechnology, how to start and manage biotechnology companies, and how to better service the needs of biotechnology companies. This acclaimed book describes the convergence of scientific, political, regulatory, and commercial factors that drive the biotechnology industry and define its scope. In addition to its popularity among ... Read more

    $55.99 CAD

  • Financial Accounting

    Budgets can be used by assessing the employees. There are different types of budgets, Start up budget, Sales budget, and Summary budget. Working capital, also known as net working capital or NWC, is a financial metric which represents operating liquidity available to a business. Along with fixed assets such as plant and equipment, working capital is considered a part of operating capital.Get now ... Read more

    $1.85 CAD or Free with Kobo Plus

  • Sickening

    How Big Pharma Broke American Health Care and How We Can Repair It

    by John Abramson ...
    The inside story of how Big Pharma’s relentless pursuit of ever-higher profits corrupts medical knowledge—misleading doctors, misdirecting American health care, and harming our health.The United States spends an excess $1.5 trillion annually on health care compared to other wealthy countries—yet the amount of time that Americans live in good health ranks a lowly 68th in the world. At the heart of ... Read more

    Was $18.99 CAD Now $2.99 CAD

  • Introduction to Private Equity

    by Cyril Demaria ...
    Series Book 506 - The Wiley Finance Series
    Introduction to Private Equity is a critical yet grounded guide to the private equity industry. Far more than just another introductory guide, the book blends academic rigour with practical experience to provide a critical perspective of the industry from a professional who has worked at many levels within the industry, including insurance, funds of funds, funds and portfolio companies.The book ... Read more

    $42.99 CAD